Predictors of cladribine effectiveness in multiple sclerosis: a real-world, multicenter, two-year follow-up study

被引：0
|
作者：
Petracca, M. [1 ]
Ruggieri, S. [1 ,2 ]
Barbuti, E. [3 ]
Ianniello, A. [1 ]
Fantozzi, R. [4 ]
Di Lemme, S. [4 ]
Maniscalco, G. [5 ]
Landi, D. [6 ]
Marfia, G. [6 ]
Di Gregorio, M. [7 ]
Iodice, R. [8 ,9 ]
Sinisi, L. [10 ]
Missione, R. [11 ]
Coppola, C. [11 ]
Bonavita, S. [11 ]
Borriello, G.
Lus, G. [11 ]
Pozzilli, C. [1 ]
Signoriello, E. [11 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Rome, Italy
[2] Sapienza Univ, MS Ctr, S Andrea Hosp, Rome, Italy
[3] IRCCS Neuromed, Neurol Unit, Pozzilli, Italy
[4] A Cardarelli Hosp, Multiple Sclerosis Ctr, Naples, Italy
[5] Tor Vergata Univ, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy
[6] Azienda Osped Univ San Giovanni Dio & Ruggi Arago, Salerno, Italy
[7] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy
[8] San Paolo Hosp, Div Neurol, Naples, Italy
[9] San Paolo Hosp, MS Ctr, Naples, Italy
[10] Univ Campania Luigi Vanvitelli, Multiple Sclerosis Ctr, Div Neurol 2, Dept Adv Med & Surg Sci, Naples, Italy
[11] San Pietro Fatebenefratelli Hosp, MS Ctr, Neurol Unit, Rome, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-642
引用
收藏
页码：787 / 787
页数：1
相关论文
共 50 条
  • [1] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Petracca, Maria
    Ruggieri, Serena
    Barbuti, Elena
    Ianniello, Antonio
    Fantozzi, Roberta
    Maniscalco, Giorgia Teresa
    Andreone, Vincenzo
    Landi, Doriana
    Marfia, Girolama Alessandra
    Di Gregorio, Maria
    Iodice, Rosa
    Sinisi, Leonardo
    Maida, Elisabetta
    Missione, Rosanna
    Coppola, Cinzia
    Bonavita, Simona
    Borriello, Giovanna
    Centonze, Diego
    Lus, Giacomo
    Pozzilli, Carlo
    Signoriello, Elisabetta
    [J]. NEUROLOGY AND THERAPY, 2022, 11 (03) : 1193 - 1208
  • [2] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Maria Petracca
    Serena Ruggieri
    Elena Barbuti
    Antonio Ianniello
    Roberta Fantozzi
    Giorgia Teresa Maniscalco
    Vincenzo Andreone
    Doriana Landi
    Girolama Alessandra Marfia
    Maria Di Gregorio
    Rosa Iodice
    Leonardo Sinisi
    Elisabetta Maida
    Rosanna Missione
    Cinzia Coppola
    Simona Bonavita
    Giovanna Borriello
    Diego Centonze
    Giacomo Lus
    Carlo Pozzilli
    Elisabetta Signoriello
    [J]. Neurology and Therapy, 2022, 11 : 1193 - 1208
  • [3] A prospective observational longitudinal study with a two-year follow-up of multiple sclerosis patients on Cladribine
    Al-Hashel, Jasem
    Ahmed, Samar Farouk
    AlMojel, Malak
    Alroughani, Raed
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 232
  • [4] Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing
    Manni, A.
    Oggiano, F.
    Palazzo, C.
    Panetta, V.
    Gargano, C. D.
    Mangialardi, V.
    Guerra, T.
    Iaffaldano, A.
    Caputo, F.
    Iaffaldano, P.
    Ruggieri, M.
    Trojano, M.
    Paolicelli, D.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
  • [5] Ocrelizumab two-year real-world safety and effectiveness over in the treatment of multiple sclerosis
    Vollmer, Brandi
    Ijadi, Nassim
    Declusin, Anthony
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    [J]. NEUROLOGY, 2021, 96 (15)
  • [6] Two-year follow-up study of primary and transitional progressive multiple sclerosis
    Ingle, GT
    Stevenson, VL
    Miller, DH
    Leary, SM
    Rovaris, M
    Barkhof, F
    Brochet, B
    Dousset, V
    Filippi, M
    Montalban, X
    Kalkers, NF
    Polman, CH
    Rovira, A
    Thompson, AJ
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (02) : 108 - 114
  • [7] Lexical access changes in patients with multiple sclerosis: A two-year follow-up study
    Sepulcre, Jorge
    Peraita, Herminia
    Goni, Joaquin
    Arrondo, Gonzalo
    Martincorena, Inigo
    Duque, Beatriz
    Velez de Mendizabal, Nieves
    Masdeu, Joseph C.
    Villoslada, Pablo
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2011, 33 (02) : 169 - 175
  • [8] Two-year real-world experience with ocrelizumab in the treatment of patients with multiple sclerosis
    Vollmer, B.
    Ijadi, N.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 595 - 596
  • [9] A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey
    Koseoglu, Mesrure
    Omerhoca, Sami
    Balci, Fatma Belgin
    Unal, Aysun
    Ozdemir, Zeynep
    Yuksel, Burcu
    Celik, Rabia Gokcen Gozubatik
    Toprak, Ufuk Emre
    Gursoy, Esra Azize
    Icen, Nilufer Kale
    Altunrende, Burcu
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1017 - 1017
  • [10] A two-year follow-up study of MRI changes and depression in 95 patients with multiple sclerosis
    Zorzon, M
    Zivadinov, R
    Ukmar, M
    Pozzi-Mucelli, RS
    Furlan, C
    Bratina, A
    Bonfigli, L
    Tommasi, MR
    Cazzato, G
    Nasuelli, D
    [J]. NEUROLOGY, 2001, 56 (08) : A256 - A256
12345